Company ARPIDA Swiss Exchange

Equities

ARPN

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

Inactive Instrument

End-of-day quote Swiss Exchange Other stock markets
- ^CHF	-

04-15	Evolva Shareholders Pass Resolutions to Revoke Liquidation, Delisting	MT
03-26	Evolva Secures Temporary Exemption from Listing Rules Amid Liquidation	MT

Evolva Holding Ltd is a Switzerland-based Company operating as a researcher for biotechnology. The Company develops and commercializes nature-based ingredients. The ingredients, produced by the Company, can be employed in, but not limited to, flavorings fragrancies, health ingredients, health protection and other various sectors. The objectives of the Company are as follows: develop technology platforms - combines biology with technology to produce nature-based ingredients; provide technology services- provides tailored services to clients across industries. The Company is focused on developing and increasing the return and effectiveness of the production of numerous ingredients within their portfolio.

CHF in Million	2021	Weight	2022	Weight	Delta
Novel Food, Nutritional and Healthcare Ingredients Product-related 95.5 %	9	92.6 %	15	95.5 %	+62.28%
Research & Development 4.5 %	1	7.4 %	1	4.5 %	-5.01%

CHF in Million	2021	Weight	2022	Weight	Delta
Switzerland 59.2 %	5	50.2 %	9	59.2 %	+85.69%
United States 40.8 %	5	49.8 %	6	40.8 %	+28.75%

Managers	Title	Age	Since
Christian Wichert CEO	Chief Executive Officer	50	07/02/22
Gerhard Lobmaier COO	Chief Operating Officer	55	31/12/20
Astrid Schäfer CTO	Chief Tech/Sci/R&D Officer	51	31/12/17
Doris Rudischhauser IRC	Investor Relations Contact	57	-
Fabienne Gschwind HRO	Human Resources Officer	51	28/02/21
Philipp Frech LAW	General Counsel	45	31/12/21

Members of the board	Title	Age	Since
Stephan Schindler CHM	Chairman	60	14/04/20
Beat In-Albon BRD	Director/Board Member	72	14/04/20
Andreas Pfluger BRD	Director/Board Member	64	31/03/22
Christoph Breucker BRD	Director/Board Member	66	31/03/21
Andreas Weigelt BRD	Director/Board Member	43	31/03/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	7,232,496	4,693,968 ( 64.90 %)	19,074 ( 0.2637 %)	64.90 %

Name	Equities	%	Valuation
Nice & Green SA 7.554 %	546,199	7.554 %	544 899 CHF
Picard Angst AG 0.0578 %	4,178	0.0578 %	4 168 CHF
DWS CH AG 0.0411 %	2,973	0.0411 %	2 966 CHF
Quorus Vermögensverwaltung AG 0.0111 %	800	0.0111 %	798 CHF
State Street Global Advisors France SA 0.006583 %	476	0.006583 %	475 CHF
Migros Bank AG 0.005255 %	380	0.005255 %	379 CHF
LLB Asset Management AG 0.003319 %	240	0.003319 %	239 CHF
Dux Inversores SGIIC SA 0.002489 %	180	0.002489 %	180 CHF
EVOLVA HOLDING SA 0.000968 %	70	0.000968 %	70 CHF

Name	Equities	%	Valuation
EVOLVA HOLDING SA 0.00%	70	0.00%	70 $

Evolva Holding SA

Duggingerstrasse 23

4153, Reinach

+41 61 485 2000

http://www.evolva.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+23.70%	52.73B
LONZA GROUP AG	+37.49%	39B
IQVIA HOLDINGS INC.	-8.86%	38.52B
ALNYLAM PHARMACEUTICALS, INC.	+28.45%	30.38B
CELLTRION, INC.	-12.26%	26.39B
ICON PUBLIC LIMITED COMPANY	+10.49%	26.08B
UNITED THERAPEUTICS CORPORATION	+44.69%	14.15B
MEDPACE HOLDINGS, INC.	+32.12%	12.6B
BIO-TECHNE CORPORATION	-6.70%	11.51B

Other Biotechnology & Medical Research